Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Susan H. Yamamura"'
Autor:
Terry O. Matsunaga, Victor J. Hruby, David F. O'Brien, Nathan Collins, Varadarajan Ramaswami, Susan H. Yamamura
Publikováno v:
Biochemistry. 32:13180-13189
NMR spectroscopic, peptide-membrane conformational studies on [D-Pen2,D-Pen5]-enkephalin (DPDPE), an opioid receptor selective peptide, and an acyclic analog of DPDPE (DPDPE reduced at the disulfide bond) were conducted. The NMR method of transferred
Autor:
Susan H. Yamamura, Michael Barfield
Publikováno v:
Journal of the American Chemical Society. 112:4747-4758
Autor:
Susan H. Yamamura, Terry O. Matsunaga, David F. O'Brien, Nathan Collins, Varadarajan Ramaswami, Victor J. Hruby
Publikováno v:
Biochemistry. 33:5356-5356
Autor:
Takashi Mimaki, W. Dale Horst, R.A. O'Brien, Henry I. Yamamura, Gordon Bautz, Susan H. Yamamura, Micaela Morelli
Publikováno v:
European Journal of Pharmacology. 77:351-354
We examined the specific binding of [ 3 H]CL 218,872, a novel triazolopyridazine to benzodiazepine receptors in the rat cerebral cortex. Two binding sites with K D values of about 10–30 nM and 200–600 nM were demonstrated. A number of benzodiazep
Autor:
Susan H. Yamamura, T.D. Reisine, H.C. Fibiger, David C. U'Prichard, Stephen T. Mason, Henry I. Yamamura, Frederick J. Ehlert
Publikováno v:
Life sciences. 26(5)
Inhibition of 3 H-dihydroalprenolol binding to rat cortex and cerebellum β-receptors by the selective β 1 -antagonist practolol, and the selective β 2 -agonist salbutamol, was shallow and biphasic, with log-logit slopes less than 1.0. The relative
Autor:
R. O'brien, Henry I. Yamamura, Takashi Mimaki, W.D. Horst, G. Bautz, Micaela Morelli, Susan H. Yamamura
The specific binding of the novel triazolopyridazine, Cl 218,872 was examined in the rat cerebral cortex. Two binding sites with dissociation constants of 10-30nM and 200-400nM were demonstrated. A number of benzodiazepine anxiolytics inhibited 3 H-C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f5f7fd7f935098ab2e30befcf174b38
https://doi.org/10.1016/b978-0-08-027988-6.50114-2
https://doi.org/10.1016/b978-0-08-027988-6.50114-2
Publikováno v:
European journal of pharmacology. 70(4)
Publikováno v:
European Journal of Pharmacology. 66:379-380